MyBlueDotsMirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MyBlueDots3 months ago01 mins FOSTER CITY, Calif.–(BUSINESS WIRE)–Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Go to Source Author: Post navigation Previous: Mettler-Toledo International Inc. to Host Fourth Quarter 2024 Earnings Conference CallNext: Clinical trial highlights promising new treatment for intestinal worms
Age-related genetic changes in the blood associated with poor cancer prognosis MyBlueDots2 days ago 0
TRIM63 identified as key gene in common heart disease, unlocking potential for earlier diagnosis MyBlueDots2 days ago 0
Newly discovered cells in connective tissue open up strategy against pancreatic cancer MyBlueDots2 days ago 0